Keywords: قطار; Cationic lipid; Metformin; Biguanide; Intrinsic antitumor activity; TRAIL; Nanoparticles
مقالات ISI ترجمه شده قطار
مقالات ISI قطار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: قطار; Training; Myokine; Erythropoietin; CTACK; TRAIL;
Keywords: قطار; 5â²AMP; 5â² adenosine monophosphate; ADO; adenosine; DSAs; anti-donor specific antibodies; APC; antigen-presenting cell; CXCL-9; chemokine (C-X-C motif) ligand 9; cAMP; cyclic adenosine monophosphate; CTLA4; cytotoxic T-lymphocyte associated protein 4;
Keywords: قطار; AIH-2; autoimmune hepatitis; Treg; regulatory T cells; NK; natural killer; TRAIL; tumor necrosis factor-related apoptosis inducing ligand; GITR; glucocorticoid-induced tumor necrosis factor-related receptor; IFNγ; interferon gamma; IL2; interleukin 2;
Keywords: قطار; 5-Aza; 5-Aza-2-deoxycytidine; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; BIR; baculoviral inhibitor of apoptosis repeat; CAD; caspase-activated deoxyribonuclease; CDK; cyclin-dependent kinase; cIAP; cellular inhibitor of apoptosis; CL
Keywords: قطار; ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-
Keywords: قطار; Death receptor; NF-κB; Caspase-8; HNSCC; TNFR; TRAIL;
Keywords: قطار; EMF; electromagnetic field; NADH; nicotinamide adenine dinucleotide; ROS; reactive oxygen species; 8-OHdG; 8-hydroxy-2'-deoxyguanosine; RNS; reactive nitrogen species; TNF; tumour necrosis factor; PKC; protein kinase C; DR; death receptor; TNFR; TNF recep
Keywords: قطار; ACLF; acute-on-chronic liver failure; AD; acute decompensation; ALT; alanine aminotransferase; ANCOVA; analysis of covariance; AST; aspartate aminotransferase; Bid; Bis in die (twice a day); DL; decilitre; HCV; hepatitis C virus; INR; international normal
Keywords: قطار; α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: قطار; T1DM; Type 1 diabetes mellitus; EDS; Search E-Resources; IGF1; insulin-like growth factor 1; NOD; non-obese diabetic; G6Pase; glucose-6-phosphatase; HGF; hepatocyte growth factor; SCID; severe combined immunodeficiency; BTC; betacellulin; Ngn3; Neurogenin
Keywords: قطار; α-SMA; α-smooth muscle actin; AIF; apoptosis inducing factor; AP-1; activator protein 1; ARE; antioxidant response element; Bax; Bcl-2 associated X protein; Bcl-2; B-cell lymphoma 2; Bcl-xl; B cell lymphoma extra large; CDKCs; cyclin:CDK complexes; c-My
Keywords: قطار; DCs; dendritic cells; NKT cells; Natural Killer T cells; BECs; biliary epithelial cells; LPS; lipopolysaccharide; PAMPs; Pathogen Associated Molecular Patterns; PRRs; pattern-recognition receptors; TLRs; Toll-like receptors; SV40; Simian Virus 40; MyD88;
Keywords: قطار; Cancer; Phytochemical; Radiotherapy; Radioprotection; Side effects; AP-1; activator protein-1; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; CAPE; caffeic acid phenylethylester; CAT; chloramphenicol acetyltransferase; CBMN; cytokinesis block
Keywords: قطار; TRAIL; Cancer; Wnt; Signaling; Apoptosis; Mushroom;
Keywords: قطار; Nanohybrids; Proteins; Polysaccharides; Drug delivery; Electrostatic nanocomplexes; Maillard conjugates; Electrospinning; 5-FU; 5-Fluorouracil; α-La; α-lactalbumin; β-Lg; β-lactoglobulin; BSA; Bovine serum albumin; CMC; Carboxymethyl cellulose; CMCS;
Biological properties of propolis extracts: Something new from an ancient product
Keywords: قطار; DHT; 5α-dihydrotestosterone; ABCA1; ATP-binding cassette A1; AR; androgen receptor; cIAP-2; baculoviral IAP repeat-containing protein3; Bax; Bcl-2-associated X protein; CAPE; caffeic acid phenethyl ester; ERK; extracellular signal-regulated kinases; IL1-
Keywords: قطار; TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: قطار; â¢OH; hydroxyl radical; 2,2-BP; 2,2-bipyridyl; ABC; ATP-binding cassette; AIF; apoptosis-inducing factor; AMPK; AMP-activated protein kinase; AMPKK; AMPK kinase; ANT; adenine nucleotide translocase; AP-1; activator protein 1; Apaf-1; protease activating
Keywords: قطار; Ovarian cancer; Chemotherapy resistance; Natural compounds; Autophagy; Apoptosis; Ovarian cancer stem-like cells; ABCG2; ATP-binding cassette G2; AE; Amla extracts; Akt; protein kinase B; ALDH1; aldehyde dehydrogenase 1; ARE; antioxidant-response element;
Keywords: قطار; EOC; epithelial ovarian cancer; SNP; single nucleotide polymorphisms; O2â¢â; superoxide; H2O2; hydrogen peroxide; NAD(P)H; nicotinamide adenine dinucleotide phosphate; iNOS; inducible nitric oxide synthase; MPO; myeloperoxidase; SOD; superoxide dismuta
Keywords: قطار; HS; hemorrhagic shock; AKI; acute kidney injury; TBSA; total body surface area; GFR; glomerular filtration rate; BUN; blood urea nitrogen; RIFLE; Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease; ADQI; Acute Dialysis Quality Initia
Keywords: قطار; AIF; apoptosis inducing factor; Ang; angiopoietin; AP-1; activator protein-1; APEX; Assessment of Proteasome Inhibition for Extending Remissions; ATP; adenosine-5â²-triphosphate; BiPN; bortezomib-induced peripheral neuropathy; CiPN; chemotherapy-induced
Keywords: قطار; AIPC; Androgen-independent prostate cancer; AKAP1; cAMP signaling; AML; acute myeloid leukemia; BAK; Bcl-2 homologous antagonist killer; BAX; Bcl-2-associated X protein; BCL-2; B-cell lymphoma 2; BMRP; BCL-2 interacting mitochondrial ribosomal protein; C7
Keywords: قطار; PMNs; polymorphonuclear leukocytes; TANs; Tumor associated neutrophils; N1; proinflammatory; N2; anti-inflammatory tumor-promoting neutrophils; ELA2; neutrophil elastase; MMP8; neutrophils collagenase; MMP9; neutrophils gelatinase B; ECM; extracellular ma
Keywords: قطار; BDCA-2; blood dendritic cell antigen-2; CD123; interleukin-3 receptor α chain; CTL; cytotoxic CD8 T lymphocyte; DC; dendritic cell; GZMB; granzyme B; IFN; interferon; IL; interleukin; ILT7; immunoglobulin superfamily receptor immunoglobulin-like transcri
Keywords: قطار; HDACs; TRAIL; Therapeutic intervention
Keywords: قطار; Necroptosis; Smac mimetic; Cell death; Pancreatic carcinoma; IAP proteins; cIAP; cellular IAP; FADD; Fas-associated protein with death domain; FCS; fetal calf serum; GAPDH; anti-glyceraldehyde 3-phosphate dehydrogenase; IAP; inhibitor of apoptosis; MLKL;
Keywords: قطار; BMI; Body mass index; T2DM; Type 2 diabetes mellitus; MHO; Metabolically healthy but obese; MUHNW; Metabolically unhealthy normal weight; MUHO; Metabolically unhealthy obese; MAO; Metabolically abnormal obese; LDL; Low density lipoprotein; HDL; High densi
Keywords: قطار; ACTH; adrenocorticotropic hormone; aFGF; acidic fibroblast growth factor; Akt; activation of protein kinase B; ANG; angiogenin; ASCs; adipose tissue-derived mesenchymal stem cells; B7-H1; B7 homolog 1; BDNF; brain-derived neurotrophic factor; bFGF; basic
Keywords: قطار; CIA; chemotherapy-induced alopecia; Cph; cyclophosphamide; DP; dermal papilla; ORS; outer root sheath; TRAIL; tumor necrosis factor-related apoptosis-inducing ligand; TRP1; tyrosinase-related protein 1;
Keywords: قطار; Nanotechnology; Liposomes; Tumor-draining lymph nodes; TRAIL; Natural killer cells;
Keywords: قطار; Localized drug delivery; TRAIL; Anti-cancer efficacy; Nanotube arrays; Tumour regression
Keywords: قطار; PBS; phosphate buffered saline; FBS; fetal bovine serum; DR5; death receptor 5; α-DR5; anti-DR5 agonist antibody; TNF; tumor necrosis factor; TNFR; TNF receptor; TRAIL; TNF-related apoptosis-inducing ligand; TM; transmembrane; MβCD; methyl-β-cyclodextr
Keywords: قطار; Liver; Immunity; Tolerance; Autoimmunity; Antigen presentation; Innate lymphocytes; AIH; autoimmune hepatitis; ALD; autoimmune liver disease; APC; antigen-presenting cell; CTLA-4; cytotoxic T cell antigen-4; DC; dendritic cell; α-GC; α-galactosylceramid
Keywords: قطار; IFN-α; interferon alpha; IFN-γ; interferon gamma; TIL; tumor infiltrating lyphocyte; TRAIL; TNF-related apoptosis-inducing ligand; IP; intra-peritoneal; Monocyte; Interferon alpha; Interferon gamma; Ovarian cancer; Immunotherapy;
Keywords: قطار; Aβ; amyloid beta; AD; Alzheimer's disease; AIS; acute ischaemic stroke; AJ; adherens junctions; ApoE; apolipoprotein E; APP; amyloid precursor protein; BBB; blood-brain barrier; BMVEC; brain microvascular endothelial cells; CD; cluster of differentiation
Keywords: قطار; 8-OHdG; 8-oxo-2â²-deoxyguanosine; AMPK; AMP-activated protein kinase; ANT; adenine nucleotide translocator; Bad; Bcl2-associated agonist of cell death; BKA; bongkrekic acid; CAT; catalase; CsA; cyclosporine A; Cu/Zn-SOD; Cu/Zn-superoxide dismutase; DR4;
Keywords: قطار; Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: قطار; ADH; adipic acid dihydrazide; AUNPs; gold nanoparticles; BA; butyric acid; CDDP; cisplatin; CHI; chitosane; CNTs; carbon nanotubes; CPT; camptothecin; CSCs; cancer stem cells; DiPhPE; diphytanoyl-sn-glycero-3-glycerophosphatidyl ethanolamine; DL; drug loa
Keywords: قطار; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; Apaf-1; apoptotic protease activating factor 1; CAD; caspase-activation DNase; cyt c; cytochrome c; Cy; cyclophilin; Drp-1; dynamin-related protein 1; ENDO; endonuclease; AIF; apoptosis-inducing
Keywords: قطار; Acute lymphoblastic leukaemia; APRIL; BAFF; TRAIL;
Keywords: قطار; Antioxidant; Oxidative stress; Redox; Tumor; Cancer therapy; Akt; protein kinase B; AMPK; 5â²-adenosine monophosphate-activated protein kinase; ATM; ataxia telangiectasia-mutated; DR5; death receptor 5; EC; epicatechin; ECG; epicatechin-3-gallate; EGC; e
Keywords: قطار; Pulmonary hypertension; Tumor necrosis factor-related apoptosis-inducing ligand; Mouse model; 6MWD; 6-min walk distance; CAD; coronary artery disease; CHD; congenital heart disease; CTD; connective tissue disease; CTEPH; chronic thromboembolic pulmonary
Keywords: قطار; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; RT; radiotherapy; SHARP; a phase III study of Sorafenib in patients with advanced HCC; DR5; death receptor 5; TRAIL; tumour necrosis factor-related apoptosis-inducing ligand; D
Keywords: قطار; Hyaluronic acid; TRAIL; Conjugate; Targeted delivery; Liver fibrosis;
Keywords: قطار; TUNEL; terminal deoxynucleotidyl transferase dUTP nick-end labeling; ELISA; enzyme-linked immunosorbent assay; DNA; deoxyribonucleic acid; TNFα; tumor necrosis factor-alpha; Foxa2; forkhead box protein A2; HNF6; hepatocyte nuclear factor 6; C/EBPα; CCAA
Keywords: قطار; ACI; Autologous chondrocyte implantation; ACPCs; Articular cartilage progenitor cells; ASCs; Adipose stem cells; BMP; Bone morphogenetic protein; Bcl-2; B-cell lymphoma 2; Bcl-xL; B-cell lymphoma-extra large; BCA-1; B cell-attracting chemokine 1; CCR6;
Keywords: قطار; ADP; adenosine diphosphate; ANT; adenine nucleotide transporter; ATP; adenine triphosphate; C1QBP; complement component 1Q subcomponent-binding protein; Ca2Â +; calcium; CK; creatine kinase; CsA; cyclosporine A; CYCLE; CYCLosporinE A in reperfused acute m
Keywords: قطار; apoptosis; cancer; mesenchymal stromal cell; TRAIL; tumor;